Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for AMANTADINE HYDROCHLORIDE
- Amantadine Therapy for Cognitive Impairment in Long COVID
- Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU
- Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis
- The Effect of Amantadine on Post-COVD-19 Fatigue
- Amantadine for Neuroenhancement in Acute Patients Study
- Promoting Recovery After STroke With Amantadine
- Efficacy of Amantadine Treatment in COVID-19 Patients
- Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant Depression
- Amantadine for COVID-19
- Post-stroke Epilepsy: Primary Prophylaxis Study
- Study to Investigate the Effect of Hypoestes Rosea Powder in Parkinson's Disease
- The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms
- Bioequivalence Study of Favipiravir 200 mg Film Tablet (Pharma Plant, Turkey) Under Fasting Conditions
- Impact of Amantadine on Traumatic Brain Injury
- Bioequivalence Study of Favir 200 mg Film Tablet Kocak Under Fasting Conditions
- Combination Treatment With Cerebrolysin and Amantadine on Patients Who Stays in Prolonged Disorders of Consciousness Due to Severe Traumatic Brain Injury
- Bioequivalence Study of Favipiravir 200 mg Film Tablet (World Medicine, Turkey) Under Fasting Conditions
- Bioequivalence Study of Favipiravir 200 mg Film Tablet (ATABAY, Turkey) Under Fasting Conditions
- Bioequivalence Study of Favipiravir 200 mg Film Tablet (Novelfarma, Turkey) Under Fasting Conditions
- Effect of GOCOVRI (Amantadine, Extended Release Capsules) on Gait in Parkinson's Disease
- Amantadine in Treating Cognitive & Motor Impairments in Adolescents and Adults With Cerebral Palsy
- Is Long-term Use of Amantadine Effective in PD?
- Changes in Glutamatergic Neurotransmission of Severe TBI Patients
- Clinical Study on Treatment of L-DOPA-Induced Dyskinesia With Tianqi Pingchan Granule Combined With Amantadine
- Brain Correlates of Multimodal Rehabilitation in Chronic Post-stroke Aphasia
- Evaluation of the Effect of Preoperative Intravenous Amantadine Sulfate on the Postoperative Early Cognitive Functions in a Elderly Patient With Laparoscopic Radical Prostatectomy
- Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.
- Oral Amantadine, IV Amantadine and Hemodynamic Response to Laryngoscopy
- A Safety and Efficacy Study of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
- Effects of Amantadine on Postoperative Cognitive Dysfunction
- Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment
- Citicholine-Amantadine Trial in Traumatic Brain Injury
- Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple Sclerosis
- Amantadine Sulphate Usage in Spine Deformities Corrective Surgeries Patients
- Oral Amantadine Versus Gabapentin to Attenuate the Response to Laryngoscopy and Tracheal Intubation
- Inhaled Nitric Oxide After Out-of-Hospital Cardiac Arrest
- A Study of Oxidative Pathways in MS Fatigue
- Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease
- Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia
- Amantadine and Functional Improvement Following ABI Measured by MRI Tractography; A Pilot Study
- Amantadine to Speed Awakening After Cardiac Arrest
- Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
- Effect of Amantadine Administration on Spatial Functioning Following Traumatic Brain Injury
- Testing the Effects of Methylphenidate on Multiple Sclerosis
- Acetylamantadine Excretion by Cancer Patients
- Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
- An Open-Label Trial of Memantine for Cognitive Impairment in Patients With Post-Traumatic Stress Disorder
- Open-Label Safety Study of ADS-5102 in PD Patients With LID
- Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.
- Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID
- ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
- Amantadine + rTMS as a Neurotherapeutic for Disordered Consciousness
- Methylphenidate as Treatment Option of Fatigue in Multiple Sclerosis
- Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
- Efficacy Study of Amantadine to Treat Gait Dysfunction and Freezing in Parkinson's Disease
- Reducing Dyskinesia in Parkinson's Disease With Omega-3 Fatty Acids
- Oseltamivir for Influenza Lower Respiratory Tract Infection in Children Under One
- Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease
- Urinary Excretion of Acetylamantadine by Normal Healthy Volunteers
- Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes Subjects
- Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
- Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults
- Effect of Intravenous Amantadine on Gait Freezing in Parkinson's Disease
- The Effect of IV Amantadine on Freezing of Gait (FOG) Resistant to Dopaminergic Therapy
- A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)
- Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications
- An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)
- Pilot Study of Maintenance Therapy With Intravenous AMANTADINE
- Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease
- Amantadine Versus Ritalin in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD)
- Validation of Dyskinesia Rating Scales
- Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia
- A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection
- Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects
- Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation
- Effectiveness of Amantadine Hydrochloride for Treatment of Severe Traumatic Brain Injury (TBI)
- Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia
- TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients
- Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection
- Action of Amantadine on Post-Stroke Aphasic Patients
- Amantadine and Temporal Discrimination in Patients With Traumatic Brain Injury (TBI)
- Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease
- Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study
- Urinary Excretion of Acetylamantadine by Cancer Patients
- American Ginseng Treatment for Multiple Sclerosis Related Fatigue
- Amantadine for Treatment of Symptoms of the Post-traumatic Confusional State
- Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
- Long-Term Effects of Amantadine in Parkinsonian (AMANDYSK)
- Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa
- Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability
- Perioperative Treatment of Parkinsonian Patients With Parenteral Amantadine
- Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS
- Aspirin for Treatment of Multiple Sclerosis-Related Fatigue
- Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With Amantadine
- Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine
- Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination Therapy
- High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza
- Study of Amantadine for Weight Stabilization During Olanzapine Treatment
- Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients
- Fatigue Treatment Using Provigil
- Abilify Therapy for Reducing Comorbid Substance Abuse
- Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM
- Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy
- Study of Long-term Peg Intron vs. Colchicine in Non-responders.
- Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2
- Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients
- Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA)
- Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)
- Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders
- Talampanel to Treat Parkinson's Disease
- Levetiracetam Treatment of L-dopa Induced Dyskinesias
- Prepulse Inhibition of Startle in Cocaine Dependence - 7
- Treatment of Huntington's Chorea With Amantadine
- Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4
Clinical trials list
click for details